Dell Faulkingham - Net Worth and Insider Trading

Dell Faulkingham Net Worth

The estimated net worth of Dell Faulkingham is at least $183,614 dollars as of 2024-04-28. Dell Faulkingham is the SVP, CCO of Akebia Therapeutics Inc and owns about 137,025 shares of Akebia Therapeutics Inc (AKBA) stock worth over $183,614. Details can be seen in Dell Faulkingham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dell Faulkingham has not made any transactions after 2021-04-01 and currently still holds the listed stock(s).

Transaction Summary of Dell Faulkingham

To

Dell Faulkingham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dell Faulkingham owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .

Click here to see the complete history of Dell Faulkingham’s form 4 insider trades.

Insider Ownership Summary of Dell Faulkingham

Ticker Comapny Transaction Date Type of Owner
AKBA Akebia Therapeutics Inc 2021-04-01 CCO

Dell Faulkingham Latest Holdings Summary

Dell Faulkingham currently owns a total of 1 stock. Dell Faulkingham owns 137,025 shares of Akebia Therapeutics Inc (AKBA) as of April 1, 2021, with a value of $183,614.

Latest Holdings of Dell Faulkingham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2021-04-01 137,025 1.34 183,614

Holding Weightings of Dell Faulkingham


Dell Faulkingham Form 4 Trading Tracker

According to the SEC Form 4 filings, Dell Faulkingham has made a total of 2 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 952 shares on April 1, 2021, which brought Dell Faulkingham around $3,237.

Insider Trading History of Dell Faulkingham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dell Faulkingham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dell Faulkingham Ownership Network

Ownership Network List of Dell Faulkingham

No Data

Ownership Network Relation of Dell Faulkingham


Dell Faulkingham Owned Company Details

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

Dell Faulkingham is the CCO of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , director & CEO & President John P. Butler , and SVP & General Counsel & Sec. Nicole R. Hadas .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Dell Faulkingham made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 145,385 shares made by Michel Dahan , a net sale of 100,765 shares made by Steven Keith Burke , and a net sale of 96,282 shares made by Nicole R. Hadas .

In summary, during the past 3 months, insiders sold 132,629 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 132,629 shares. During the past 18 months, 635,551 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 635,551 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akebia Therapeutics Inc Insider Transactions

No Available Data

Dell Faulkingham Mailing Address

Above is the net worth, insider trading, and ownership report for Dell Faulkingham. You might contact Dell Faulkingham via mailing address: C/o Akebia Therapeutics, Inc., 245 First Street, Cambridge Ma 02142.

Discussions on Dell Faulkingham

No discussions yet.